{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:03:53Z","timestamp":1787317433533,"version":"build-2736575974"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,28]],"date-time":"2018-03-28T00:00:00Z","timestamp":1522195200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13104-017-2820-5","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T00:43:03Z","timestamp":1522802583000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Treatment optimization of angiotensin converting enzyme inhibitors and associated factors in Ayder Comprehensive Specialized Hospital: a cross-sectional study"],"prefix":"10.1186","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6483-2258","authenticated-orcid":false,"given":"Tesfay Mehari","family":"Atey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsegay","family":"Teklay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solomon Weldegebreal","family":"Asgedom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haftay Berhane","family":"Mezgebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gebrehiwot","family":"Teklay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molla","family":"Kahssay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,28]]},"reference":[{"key":"2820_CR1","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","volume":"62","author":"CW Yancy","year":"2013","unstructured":"Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, et al. 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;62:e147\u2013239.","journal-title":"J Am Coll Cardiol"},{"key":"2820_CR2","first-page":"735","volume":"50","author":"FDR Hobbs","year":"2000","unstructured":"Hobbs FDR. Does current prescribing provide optimal treatment for heart failure patients? BJH. 2000;50:735\u201342.","journal-title":"BJH"},{"key":"2820_CR3","first-page":"279","volume":"4","author":"O Sleiman","year":"2001","unstructured":"Sleiman O, Ghanem W, Murin J. Angiotensin-converting enzyme inhibitors: do we utilize our knowledge in heart failure patients? J Clin Basic Cardiol. 2001;4:279\u201383.","journal-title":"J Clin Basic Cardiol"},{"key":"2820_CR4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/CVM-2-4-155","volume":"2","author":"E Lonn","year":"2001","unstructured":"Lonn E. Dose response of ACE inhibitors: implications of the SECURE trial. Curr Control Trials Cardiovasc Med. 2001;2:155\u20139.","journal-title":"Curr Control Trials Cardiovasc Med"},{"key":"2820_CR5","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1001\/archinte.161.2.165","volume":"161","author":"BM Massie","year":"2001","unstructured":"Massie BM, Armstrong PW, Cleland JG, Horowitz JD, Packer M, Poole-Wilson PA, et al. Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: results from the ATLAS trial. The Assessment of Treatment with Lisinopril and Survival. Arch Intern Med. 2001;161:165\u201371.","journal-title":"Arch Intern Med"},{"key":"2820_CR6","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/1071-9164(95)90021-7","volume":"1","author":"MA Konstam","year":"1995","unstructured":"Konstam MA, Dracup K, Baker DW, Bottorff MB, Brooks NH, Darcey RA, et al. Heart failure: evaluation and care of patients with left ventricular systolic dysfunction. J Card Fail. 1995;1:183\u20137.","journal-title":"J Card Fail"},{"key":"2820_CR7","doi-asserted-by":"publisher","first-page":"1A","DOI":"10.1016\/S0002-9149(99)00358-6","volume":"83","author":"M Packer","year":"1999","unstructured":"Packer M, Cohn JN, Abraham WT, Colucci WS, Fowler MB, Greenberg BH, et al. Consensus recommendations for the management of chronic heart failure. Am J Cardiol. 1999;83:1A\u201338A.","journal-title":"Am J Cardiol"},{"key":"2820_CR8","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1016\/j.jacc.2008.11.009","volume":"53","author":"M Jessup","year":"2009","unstructured":"Jessup M, Abraham WT, Casey DE, Feldman AM, Francis GS, Ganiats TD, et al. 2009 focused update: ACCF\/AHA 2005 guidelines for the diagnosis and management of heart failure in adults. J Am Coll Cardiol. 2009;53:1343\u201382.","journal-title":"J Am Coll Cardiol"},{"key":"2820_CR9","first-page":"187","volume":"50","author":"PP Messner","year":"1995","unstructured":"Messner PP, Rudnicki A, Leclercq F, Grolleau R. Enalapril in the treatment of mild-to-moderate heart failure in general medical practice: a prospective and multicentre study concerning 17,546 patients. Acta Cardiol. 1995;50:187\u2013201.","journal-title":"Acta Cardiol"},{"key":"2820_CR10","first-page":"13","volume":"5","author":"J McMurray","year":"1996","unstructured":"McMurray J. Concise guide to the management of heart failure. Am J Geriatr Cardiol. 1996;5:13\u201330.","journal-title":"Am J Geriatr Cardiol"},{"key":"2820_CR11","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1046\/j.1365-2125.1999.00093.x","volume":"48","author":"CR Gibbs","year":"1999","unstructured":"Gibbs CR, Lip GYH, Beevers DG. Angioedema due to ACE inhibitors: increased risk in patients of African origin. Br J Clin Pharmacol. 1999;48:861\u20135.","journal-title":"Br J Clin Pharmacol"},{"key":"2820_CR12","first-page":"1439","volume":"53","author":"JG Ray","year":"2007","unstructured":"Ray JG, Vermeulen MJ, Koren G. Taking ACE inhibitors during early pregnancy: is it safe? Can Fam Physician. 2007;53:1439\u201340.","journal-title":"Can Fam Physician"},{"key":"2820_CR13","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1161\/01.CIR.100.23.2312","volume":"100","author":"P Packer","year":"1999","unstructured":"Packer P, Poole-Wilson PA, Armstrong PW, Cleland JGF, Horowitz JD, Massie BM, et al. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. Cerculation. 1999;100:2312\u20138.","journal-title":"Cerculation"},{"key":"2820_CR14","doi-asserted-by":"crossref","first-page":"459","DOI":"10.5694\/j.1326-5377.2001.tb143369.x","volume":"174","author":"H Krum","year":"2001","unstructured":"Krum H. National Heart Foundation of Australia. Guidelines for management of patients with chronic heart failure in Australia. Med J Aust. 2001;174:459\u201366.","journal-title":"Med J Aust"},{"key":"2820_CR15","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S0002-9149(00)01005-5","volume":"86","author":"AB Luzier","year":"2000","unstructured":"Luzier AB, Forrest A, Feuerstein SG, Schemtag JJ, Izzo JL. Containment of heart failure hospitalizations and cost by angiotensin-converting enzyme inhibitor dosage optimization. Am J Cardiol. 2000;86:519\u201323.","journal-title":"Am J Cardiol"},{"key":"2820_CR16","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1067\/mhj.2001.113227","volume":"141","author":"YT Chen","year":"2001","unstructured":"Chen YT, Wang Y, Radford MJ, Krumholz HM. Angiotensin-converting enzyme inhibitor dosages in elderly patients with heart failure. Am Heart J. 2001;141:410\u20137.","journal-title":"Am Heart J"},{"key":"2820_CR17","doi-asserted-by":"publisher","first-page":"119","DOI":"10.4103\/0256-4947.51794","volume":"29","author":"WM Sweileh","year":"2009","unstructured":"Sweileh WM, Sawalha AF, Rinno TM, Zyoud SH, Al-Jabi SW. Optimal dosing of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: a cross-sectional study in Palestine. Ann Saudi Med. 2009;29:119\u201322.","journal-title":"Ann Saudi Med"},{"key":"2820_CR18","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1056\/NEJM200105033441802","volume":"344","author":"DV Exner","year":"2001","unstructured":"Exner DV, Dries DL, Domanski MJ, Cohn JN. Lesser response to angiotensin converting enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction. N Engl J Med. 2001;344:1351\u20137.","journal-title":"N Engl J Med"},{"key":"2820_CR19","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.amjmed.2010.06.014","volume":"123","author":"S Bangalore","year":"2010","unstructured":"Bangalore S, Kumar S, Messerli FH. Angiotensin-converting enzyme inhibitor associated cough: deceptive information from the Physicians\u2019 Desk Reference. Am J Med. 2010;123:1016\u201330.","journal-title":"Am J Med"},{"key":"2820_CR20","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S0002-9149(00)01005-5","volume":"86","author":"AB Luzier","year":"2000","unstructured":"Luzier AB. Optimization of angiotensin-converting enzyme inhibitors in a heart failure program. Am J Cardiol. 2000;86:519\u201323.","journal-title":"Am J Cardiol"},{"key":"2820_CR21","first-page":"214","volume":"53","author":"G Israel","year":"2008","unstructured":"Israel G, Shani R, Tanya AL. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high-risk clinical and ethnic groups with diabetes. IMAJ. 2008;53:214\u20138.","journal-title":"IMAJ"},{"key":"2820_CR22","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/S0140-6736(00)02060-2","volume":"355","author":"RW Troughton","year":"2000","unstructured":"Troughton RW, Frampton CM, Yandle TG, Espiner EA, Nicholls MG, Richards AM. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (n-BNP) concentrations. Lancet. 2000;355:1126\u201330.","journal-title":"Lancet"},{"key":"2820_CR23","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1053\/euhj.2002.3178","volume":"23","author":"The European Society of Cardiology","year":"2002","unstructured":"The European Society of Cardiology. Optimization of ACE inhibitor therapy in heart failure. Eur Heart J. 2002;23:1323\u20135.","journal-title":"Eur Heart J"},{"key":"2820_CR24","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1161\/01.CIR.100.23.2312","volume":"100","author":"M Packer","year":"1999","unstructured":"Packer M, Poole-Wilson PA, Armstrong PW, Cleland JG, Horowitz JD, Massie BM, et al. ATLAS trial. Circulation. 1999;100:2312\u20138.","journal-title":"Circulation"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-017-2820-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13104-017-2820-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-017-2820-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,13]],"date-time":"2019-10-13T22:10:31Z","timestamp":1571004631000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-017-2820-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,28]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2820"],"URL":"https:\/\/doi.org\/10.1186\/s13104-017-2820-5","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,28]]},"assertion":[{"value":"26 October 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"209"}}